brain tumors: Microwave News Article Archive (2004 - )
The incidence of glioblastoma multiforme (GBM), the most virulent and deadly type of brain cancer, is going up in the U.K., while the incidence there of other types of malignant brain tumors are declining, according to some newly published raw data.
Take a look at the two plots below and the trends are immediately apparent.
The incidence rates are not corrected for age, or...
Novocure’s 200 kHz signals kept 43% of GBM patients alive compared to 30% on the standard treatment.
The latest analysis from Interphone. The same tensions continue with no clear consensus.
For more on Novocure, going back to 2007, follow this link.
The latest on NovoCure’s EM therapy for brain tumors. Not a cure; it increases overall survival time by about three months. The cost is high: $21,000/month. See also our other stories about NovoCure going back to 2007.
“Decreased Survival of Glioma Patients with Astrocytoma Grade IV (GBM) Associated with Long-Term Use of Mobile and Cordless Phones,” by Sweden’s Michael Carlberg and Lennart Hardell, International Journal of Environmental Research and Public Health, posted online October 16, 2014.
Those who first used wireless phones before the age of 20 have a higher brain tumor risk and a shorter survival time, Hardell told us. This paper, along with others like a recent German-Iranian paper, call for an “urgent revision of current exposure guidelines,” they write. Open access.
INTEROCC and INTERPHONE have a lot in common —more than their first five letters. So much in common that it’s a bit freaky. Or, maybe it just shows, once again, how small, insulated and polarized the EMF community is.
The most obvious parallels are that Elisabeth Cardis is the principal investigator of both the...
The new INTEROCC paper raises an intriguing question: Might the ELF component of GSM phone radiation present a brain tumor risk?
To date, all the attention on the cancer risk from mobile phones has been on RF radiation. Now that INTEROCC points to a credible association between exposure to ELF EMFs and brain tumors (see main story), is it possible, we have been focusing on the...
“In our study, we found an increased risk in those subjects reporting a prolonged use, making numerous calls, whose use was especially occupational and more often in urban areas…” For ≥ 986 h of life-long use, OR=2.89, 95% CI: 1.41-5.93 for gliomas; OR=2.57, 95% CI: 1.02-6.44 for meningiomas; for ≥18,360 calls, OR=2.10, 95% CI: 1.03-4.31 for gliomas. (All these elevated risks are statistically significant.) From Bordeaux University Segalen, France.
“For lung, breast and brain cancer, we found no evidence of an association.…We did observe associations between ELF-EMF exposure and follicular lymphoma and acute myeloid leukemia in men although AML did not show clear exposure-response relationship.” From the Institute for Risk Assessment Sciences at Utrecht University.
“Environmental Risk Factors for Cancers of the Brain and Nervous System: The Use of Ecological Data to Generate Hypotheses,” Occupational & Environmental Medicine, May 2013, by Frank de Vocht and coworkers at U.K.'s University of Manchester.
“We show a clear association between national penetration of cellular telecommunications subscriptions and higher incidence of brain and nervous system cancers, with a latency between exposure and clinical onset of at least 11–12 years, but probably more than 20 years.”
Using a new data set covering 2007-2009, Lennart Hardell and his research team have reaffirmed their previous findings that long-term use of a wireless phone leads to higher rates of both malignant brain tumors and acoustic neuromas (AN), but not of meningiomas, a type of benign brain tumor. In general, they report, the longer the use, the greater the risk for AN and malignant brain tumors.
All three new papers are open access. For the malignant brain tumor paper, click here; for the AN paper...
The Danish Cancer Society is reporting that the number of men diagnosed with glioblastoma —the most malignant type of brain cancer— has nearly doubled over the last ten years. Hans Skovgaard Poulsen, the head of neuro-oncology at Copenhagen University Hospital, is calling it a "frightening development...
Asian-Pacific Journal of Cancer Prevention, 2011 (open access).
“I am the happiest man alive,” says Robert Dill-Bundi, the Swiss Olympic cycling champion. Dill-Bundi developed a glioblastoma multiforme, an aggressive, usually fatal, type of brain tumor, but is still alive years after being treated with electric fields. The therapy was developed by Novocure, an Israeli company (see: ...